VelosBio, a biotech firm focused on oncology, has raised $58 million in Series A funding. Arix Bioscience plc and Sofinnova Ventures led the round with participation from other other investors that included Pappas Ventures, Chiesi Ventures, Takeda Ventures Inc and Decheng Capital. In conjunction with the funding, Mark Chin, Arix investment director, will join the VelosBio board of directors.
1 min read · 01 October 2018
Oakland, California-based Modis Therapeutics, a developer of medicines for patients with rare genetic diseases, has raised $30 million in Series A funding. F-Prime Capital Partners and OrbiMed led the round.
1 min read · 01 October 2018
Emeryville, California-based Gritstone Oncology Inc, a developer of tumor-specific cancer immunotherapies, has raised about $100 million after pricing its IPO of over 6.6 million shares at $15 per share. The stock began trading September 28, 2018 on the NASDAQ under the ticker symbol "GRTS." Goldman Sachs, Cowen and Company LLC and Barclays Capital Inc are the lead underwriters. Gritstone Oncology’s pre-IPO backers included Versant Ventures, The Column Group, Clarus Funds, Frazier Healthcare Partners, RedMile, Casdin Capital, Lilly Asia Ventures, Trinitas Capital, GV, Alexandria Venture Investments and Bay City Capital.
3 min read · 28 September 2018
Shanghai-based CooTek, a global mobile internet company, has raised $52.2 million for its IPO after pricing its 4.35 million shares at $12 per share. The stock began trading September 28, 2018 on the New York Stock Exchange under the ticker symbol "CTK." Credit Suisse Securities (USA) LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Citigroup Global Markets Inc are the lead underwriters. CooTek's pre-IPO backers included Sequoia Capital China, Qiming Venture Partners and New Alliance Capital, according to Crunchbase.
3 min read · 28 September 2018
Oakland, California-based Broadly, a marketing startup focused on helping small businesses generate positive online reviews, has raised $10 million in Series B funding. Foundry Group and Calibrate Ventures led the round with participation from Team Builder Ventures.
1 min read · 28 September 2018
UK-based SLAMcore, a developer of spatial artificial intelligence algorithms for robots and drones, has raised $5 million in funding. Amadeus Capital Partners led the round with participation from Mirai Creation Fund, Toyota AI Ventures, MMC Ventures and Octopus Ventures.
1 min read · 28 September 2018
San Diego and India-based Netradyne, a provider of artificial intelligence technology focused on driver and fleet safety, has raised $21 million in Series B funding. The investors included Reliance Industries Limited, M12, Microsoft's corporate venture arm and Point72 Ventures.
1 min read · 28 September 2018
Cleveland, Ohio-based Checkpoint Surgical Inc, a medical device company, has raised $8.8 million in funding. Mutual Capital Partners led the round with participation from other investors that included First Analysis and the JumpStart NEXT Fund.
1 min read · 28 September 2018
Cambridge, Massachusetts-based drug developer KSQ Therapeutics has secured $80 million in Series C financing. The investors included Baillie Gifford, Cowen Healthcare Investments, Invus, Lilly Asia Ventures, Flagship Pioneering, Polaris Partners, ARCH Venture Partners and Alexandria Equities.
1 min read · 28 September 2018
UK-based Softomotive, a provider of robotic process automation solutions, has raised $25 million in Series A financing. The investor was Grafton Capital.
1 min read · 28 September 2018
